Cytokinetics grants inducement stock options and RSUs under Nasdaq rule
Cytokinetics said inducement grants were made on Sept. 15, 2026: stock options for 52,834 shares and RSUs for 35,025 shares to be settled in common stock.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.